FOLR1 and neoplasm: Under the assumption that the protein expression in the EVs is reflective of tumour‐derived expression patterns, a decreased FR‐alpha/FOLR1 level in EVs at progression could indicate a more effective treatment regimen, as the proliferation rate slows down in conjunction to the decreased cellular influx of folate.